Device Challenge Aerosol testing evaluates how sensors, collectors, respiratory-protection products, and mitigation devices respond to controlled biological or particle-tracer aerosols. To establish the reference challenge concentration, ARE Labs combines Collison nebulizers with controlled airflow, environmental logging, and qPCR, ddPCR, or fluorescence quantitation. The work is conducted under ISO 17025 controls, with methods aligned to ASTM, EN, or 42 CFR frameworks when appropriate for the device class:
- Bioaerosol detector sensitivity mapping for fixed or fieldable instruments, using Collison-generated targets and ISO 17025 reference sampling to define detection limits.
- Respiratory-protection product comparisons under ASTM F2299, EN 149, or 42 CFR Part 84 context, using particle counters and tracer aerosols to map penetration and response.
- Medical-mask or barrier-device challenge studies aligned to ASTM F2101 or EN 14683, using biological or fluorescent tracers to compare capture performance.
- Air-treatment and collector validation under ISO 17025 controls, using chamber or duct releases with reference impingers, filters, and qPCR or ddPCR quantitation.
- Alert-logic and false-alarm evaluation for bioaerosol sensors, using defined backgrounds, blanks, and replicate release sequences within an ISO 17025 quality system.
Use this service when a device must respond to a defined aerosol challenge rather than a nominal specification. Before method selection, the study plan defines the target, background conditions, airflow field, decision threshold, and reference recovery workflow.